Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

XENICAL 120 mg CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/XENICAL 120 mg CAPSULAS DURAS

Approved

STANDARD

XENICAL 120 mg CAPSULAS DURAS

Cheplapharm Arzneimittel Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 15, 2021
Approval ID: 08b4caa644029233
Company: Cheplapharm Arzneimittel Gmbh
Type: Standard

Approval Details

Approval Id: 08b4caa644029233
Drug Cima Aemps Name: XENICAL 120 mg CAPSULAS DURAS
Register Number: 98071003IP8
Holder Company Name: Cheplapharm Arzneimittel Gmbh
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/cheplapharm-arzneimittel-gmbh
Authorization Date: 2021-07-15
Dosage Form: CÁPSULA DURA
Dose: 120 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Cheplapharm Arzneimittel Gmbh
Company Detail Path: /organization/cheplapharm-arzneimittel-gmbh

Company Information

Pharmaceutical Company Name: Cheplapharm Arzneimittel Gmbh
Country Name: Norway
City Name: utlandet,country_no
Address: Ziegelhof 24DE-17489 GREIFSW
Website: http://www.cheplapharm.com

Active Ingredients

ORLISTAT

120 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 15, 2021

Approval ID

08b4caa644029233

Type

Standard

Back to CIMA-AEMPS Approvals